Medicamen Organics Limited IPO: Financial Analysis, Opening Dates, GMP & Subscription Details

   3.8 ( 4 votes)
Posted By : Shubham Singh
295 Views
     

Offer Details

Medicamen Organics Limited IPO: What Investors need to know?

Company Overview

Medicamen Organics Limited, established in 1995 and headquartered in New Delhi, is a pharmaceutical company that manufactures and markets a broad range of pharmaceutical formulations, including tablets, capsules, syrups, ointments, and more. The company is renowned for its quality products and commitment to innovation.

Promoter: Mr. Bal Kishan Gupta

Registered Office:
10 Community Centre No 2, Ashok Vihar Phase II, New Delhi, Delhi, 110052, India

Company Secretary & Compliance Officer: Ms. Varsha Bansal
Chief Financial Officer: Mr. Lalit Gupta
Docs: Medicamen DRHP

Medicamen Organics IPO Details

Issue Type 100% Book Built Issue IPO
Fresh Issue Size Up to 32,00,000 Equity Shares
Face Value ₹10 per Equity Share
Price Band ₹32 to ₹34 per share
Lot Size 4000 Shares
Total Issue Size 3,100,000 shares
Fresh issue 3,100,000 shares
Listing Proposed on NSE Emerge
Lead Manager GYR Capital Advisors Private Limited
Registrar KFIN Technologies Limited

IPO Important Dates

Event Date
IPO Open Date Friday, June 21, 2024
IPO Close Date Tuesday, June 25, 2024
Basis of Allotment Wednesday, June 26, 2024
Initiation of Refunds Thursday, June 27, 2024
Credit of Shares to Demat Thursday, June 27, 2024
Listing Date Friday, June 28, 2024
Cut-off time for UPI mandate confirmation 5 PM on June 25, 2024

Medicamen Organics Limited Financial Performance

Period Ended 31 Mar 2024 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 3,858.07 3,211.98 2,707.21 2,634.37
Revenue 2,528.96 2,296.24 2,118.67 2,505.96
Profit After Tax 240.41 95.78 9.23 29.81
Net Worth 1,518.40 851.71 755.92 746.72
Reserves and Surplus 658.40 251.71 155.92 146.72
Total Borrowing 1,265.65 1,179.50 1,024.57 958.97

Amount in ₹ Lakhs

Objectives of the IPO

  1. Expansion of manufacturing facilities.
  2. Investment in research and development.
  3. Repayment of certain borrowings.
  4. General corporate purposes.

Industry Overview

The Indian pharmaceutical industry is one of the largest globally, with significant contributions to generic drug production. The sector is poised for substantial growth due to increasing healthcare awareness, an aging population, and favorable government policies. Medicamen Organics Limited, with its strong market presence and diverse product portfolio, is well-positioned to capitalize on these opportunities.

Key Strengths

  • Strong Market Presence: Established brand with a robust distribution network.
  • Diverse Product Portfolio: Wide range of pharmaceutical formulations catering to various therapeutic segments.
  • Commitment to Quality: Adherence to stringent quality standards and regulatory compliances.
  • Experienced Management: Led by a team of seasoned professionals with extensive industry knowledge.

Risks

  • Market Risks: The pharmaceutical market is highly competitive, and changes in market dynamics can impact the company’s performance.
  • Regulatory Risks: The industry is subject to stringent regulations, and changes can affect operations.
  • Operational Risks: Any disruption in manufacturing or supply chain can hinder the company’s ability to meet market demand.

Medicamen Organics Limited IPO Subscription Details

Category Subscription (times) Shares Offered Shares bid for
QIB 173.03 5,84,000 0
NII* 1,343.83 4,40,000 20,12,000
Retail 1,309.77 10,28,000 1,04,28,000
Total 993.56 20,52,000 1,24,40,000

Grey Market Premium (GMP) Live Rates

Date IPO GMP Kostak Subject to
Today ₹50 ₹- ₹140,000
25 June ₹50 ₹140,000
24 June ₹60 ₹- ₹170,000
21 June ₹60 ₹- ₹170,000
19 June ₹60 ₹- ₹170,000
18 June ₹60 ₹- ₹170,000
17 June ₹50 ₹- ₹150,000
14 June ₹5 ₹- ₹10,000


How To Get/Claim:


Conclusion

The Medicamen Organics Limited IPO presents a promising investment opportunity, backed by the company’s strong financial performance, strategic expansion plans, and established market presence. However, potential investors should carefully evaluate the associated risks and perform thorough due diligence before investing.

Disclaimer: This review is based on information available from the Draft Red Herring Prospectus (DRHP) dated February 21, 2024. Investors are advised to read the risk factors carefully and perform their own analysis before making investment decisions.

For more information, visit Medicamen Organics Limited.


SEO Headlines

  1. Medicamen Organics Limited IPO: Detailed Review, Financials, and Subscription Status
  2. Everything You Need to Know About Medicamen Organics Limited IPO
  3. Medicamen Organics Limited IPO Subscription Status and GMP Live Rates
  4. Medicamen Organics Limited IPO: Financial Performance and Key Objectives
  5. Medicamen Organics Limited IPO: Is It Worth Investing? Detailed Analysis and Review
📣 IndiaDesire is now on Telegram. Click here to join our channel (@idoffers) and stay updated with the latest loot deals & offers

Raise Your Voice:

 Hot Deals

Popular Stores

One of the Finest Loot Deals,Coupons & Free Recharge Offers Website in India

IndiaDesire.com: Online Shopping Offers, Free Recharge Coupons, Loot Deals, Amazon Offers, Flipkart Offers & Paytm Offers

We at IndiaDesire.com have been working hard since 9 years to provide you with best Shopping Experience
with an aggregated offering that helps you find great deals while also saving big bucks!